Inventor · disambiguated record
Andrius Kazlauskas
Also filed as: KAZLAUSKAS ANDRIUS
4 granted patents·2 pending applications·15 citations·filing 2001–2019
68Inventor score
Top patents by PatentIndex Score
6 records- 0176US6667173B2Nucleic acids encoding platelet derived growth factor-alpha receptorsSCHEPENS EYE RES INST·Filed 2001·Granted Dec 23, 2003·13 cites·40 claims
- 0272US9623024B2Nutlin-3A for treatment of proliferative vitreoretinopathyTHE SCHEPENS EYE RES INST INC·Filed 2013·Granted Apr 18, 2017·1 cites·18 claims
- 0365US11464773B2Nutlin-3a for treatment of proliferative vitreoretinopathySCHEPENS EYE RES INST·Filed 2019·Granted Oct 11, 2022·0 cites·17 claims
- 0458US8722015B2Compositions and methods for treatment of angiogenesis-associated ocular disordersKAZLAUSKAS ANDRIUS·Filed 2011·Granted May 13, 2014·1 cites·6 claims
- 0554US2018064708A1Nutlin-3a for Treatment of Proliferative VitreoretinopathySCHEPENS EYE RES INST·Filed 2017·Application pending·0 cites
- 0631US2007184486A1Diagnosis or treatment of endothelial cell dysfunction related diseasesKAZLAUSKAS ANDRIUS·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrius Kazlauskas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →